MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517080438 A) filed by Ac Immune Sa, Lausanne, Switzerland, on Aug. 25, for 'liposomal construct.'
Inventor(s) include Di Bonaventura, Ivan; and Ayer, Maxime.
The application for the patent was published on Sept. 12, under issue no. 37/2025.
According to the abstract released by the Intellectual Property India: "A liposomal construct comprises a liposome, at least one adjuvant; and a peptide containing at least one T-cell epitope which comprises, consists essentially of, or consists of the amino acid sequence of SEQ ID NO: 4 or an analogue thereof that retains alanine at position 2 and does not contain any methionine residues. The peptide preferably has the amino acid sequence of SEQ ID NO: 6. The liposomal construct may be used to generate a liposomal vaccine composition that additionally comprises at least one antigenic peptide displayed on the surface of the liposome. The liposomal vaccine compositions are useful in therapy. Methods of manufacture are also described."
The patent application was internationally filed on Jan. 26, 2024, under International application No.PCT/EP2024/051996.
Disclaimer: Curated by HT Syndication.
